Juan Lu Selected Research

Juan Lu Research Topics

Disease

45	Neoplasms (Cancer) 03/2022 - 06/2004
22	Nasopharyngeal Carcinoma 03/2022 - 04/2009
13	Inflammation (Inflammations) 01/2022 - 09/2010
12	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2013
10	Infections 12/2019 - 06/2005
8	Hepatocellular Carcinoma (Hepatoma) 03/2022 - 05/2003
7	Carcinogenesis 01/2022 - 03/2011
6	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2021 - 02/2007
4	Pneumonia (Pneumonitis) 01/2022 - 01/2017
4	Hypoxia (Hypoxemia) 01/2022 - 09/2006
4	Insulin Resistance 01/2021 - 01/2013
4	Acute Liver Failure (Fulminant Hepatic Failure) 01/2020 - 01/2016
4	Hypersensitivity (Allergy) 01/2018 - 12/2017
3	Sepsis (Septicemia) 09/2022 - 01/2020
3	Stroke (Strokes) 01/2022 - 07/2007
3	Ischemic Stroke 01/2022 - 10/2016
3	Heart Failure 01/2022 - 11/2017
3	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2013
3	Parkinson Disease (Parkinson's Disease) 10/2020 - 01/2019
3	Wounds and Injuries (Trauma) 06/2018 - 04/2012
3	Craniocerebral Trauma (Head Injury) 05/2012 - 08/2008
3	Hypotension (Low Blood Pressure) 08/2008 - 09/2006
3	Colonic Neoplasms (Colon Cancer) 06/2004 - 09/2003
2	COVID-19 12/2021 - 03/2021
2	Acute Coronary Syndrome 11/2021 - 01/2021
2	Liver Failure 05/2021 - 08/2015
2	Hyperlipidemias (Hyperlipidemia) 01/2021 - 01/2021
2	Obesity 01/2021 - 01/2013
2	Fibrosis (Cirrhosis) 01/2021 - 04/2019
2	Liver Diseases (Liver Disease) 01/2021 - 01/2016
2	Chronic Renal Insufficiency 01/2021 - 05/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 03/2015
2	Substance-Related Disorders (Drug Abuse) 01/2020 - 01/2020
2	Glioma (Gliomas) 07/2018 - 12/2009
2	Reperfusion Injury 10/2016 - 05/2010
2	Brain Ischemia (Cerebral Ischemia) 10/2016 - 05/2010
2	Prostatic Neoplasms (Prostate Cancer) 08/2016 - 04/2010
1	Endotoxemia 09/2022
1	Ischemia 01/2022

Drug/Important Bio-Agent (IBA)

15	MicroRNAs (MicroRNA)IBA 03/2022 - 01/2011
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2010
11	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 09/2003
8	Proteins (Proteins, Gene)FDA Link 03/2022 - 09/2005
8	Pharmaceutical PreparationsIBA 01/2022 - 12/2013
4	Long Noncoding RNAIBA 01/2022 - 01/2021
4	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 02/2007
3	LipopolysaccharidesIBA 09/2022 - 04/2011
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2022
3	Biological ProductsIBA 01/2022 - 02/2016
3	Messenger RNA (mRNA)IBA 01/2022 - 06/2009
3	C-Reactive ProteinIBA 01/2022 - 01/2021
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2015
3	Epstein-Barr Virus Nuclear AntigensIBA 01/2020 - 08/2011
3	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 12/2009
3	CytokinesIBA 08/2018 - 01/2016
3	Nicotine FDA Link 01/2018 - 12/2017
3	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2012 - 08/2008
3	Hemoglobins (Hemoglobin)IBA 08/2008 - 09/2006
3	Decitabine FDA Link 02/2004 - 09/2003
3	MethyltransferasesIBA 02/2004 - 09/2003
2	radix ophiopogonis drug combination radix ginseng fructus schizandrae (Shen Mai)IBA 09/2022 - 01/2020
2	Small Cytoplasmic RNAIBA 01/2022 - 01/2022
2	AlbuminsIBA 01/2022 - 01/2021
2	Interleukin-1 (Interleukin 1)IBA 01/2022 - 11/2017
2	Sincalide FDA Link 01/2022 - 02/2013
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022 - 11/2017
2	5-Methylcytosine (5 Methylcytosine)IBA 01/2022 - 08/2016
2	Circular RNAIBA 01/2022 - 11/2021
2	AdiponectinIBA 01/2021 - 12/2020
2	baicalinIBA 01/2021 - 04/2011
2	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2021
2	LigandsIBA 01/2021 - 01/2017
2	Blood Proteins (Serum Proteins)IBA 01/2021 - 01/2019
2	Therapeutic UsesIBA 01/2021 - 12/2009
2	Oxygen (Dioxygen)IBA 01/2021 - 10/2019
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021 - 01/2017
2	Oxidopamine (6 Hydroxydopamine)IBA 10/2020 - 01/2019
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020 - 01/2020
2	Opiate AlkaloidsIBA 01/2020 - 01/2020
2	Opioid Analgesics (Opioids)IBA 01/2020 - 01/2020
2	Antihypertensive Agents (Antihypertensives)IBA 04/2018 - 05/2015
2	Cadherins (E-Cadherin)IBA 07/2017 - 12/2010
2	Interleukin-10 (Interleukin 10)IBA 01/2017 - 04/2011
2	PowdersIBA 07/2016 - 10/2010
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 06/2016 - 04/2009
2	Endothelin-1 (Endothelin 1)IBA 06/2016 - 11/2014
2	hydroxide ionIBA 02/2013 - 04/2010
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2005 - 06/2005
2	Histones (Histone)IBA 06/2004 - 02/2004
2	Cyclin-Dependent Kinase Inhibitor p16IBA 02/2004 - 09/2003
1	Saline SolutionIBA 09/2022
1	N-methyladenosineIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022

Therapy/Procedure

18	Therapeutics 01/2022 - 12/2009
3	Immunotherapy 01/2022 - 02/2016
3	Drug Therapy (Chemotherapy) 01/2022 - 12/2009
2	Artificial Liver (Bioartificial Liver) 05/2021 - 01/2016
2	Lasers (Laser) 01/2021 - 01/2016
2	Moxibustion 08/2020 - 01/2019
2	Aftercare (After-Treatment) 01/2018 - 12/2013